Ginsenoside Rh7 May Help Regulate Clotting After Hip Surgery
Lab research suggests this ginseng compound could eventually help stabilize clotting balance for hip surgery patients.
Updated on Oct. 16, 2026 in Stroke
Live Poll
Would you trust traditional herbal compounds to support your recovery after a major surgery?
Researchers have identified ginsenoside Rh7 as a potential regulator of blood clotting processes following total hip arthroplasty. This preclinical study offers new insight into how specific compounds from ginseng may help balance fibrinolytic activity to prevent postoperative complications.
Why it matters
Postoperative fibrinolytic imbalance after total hip arthroplasty significantly increases the risks of both bleeding and thrombosis. Finding new ways to regulate these pathways is critical for improving patient outcomes during surgical recovery.
This preclinical study identified 65 key biological targets involved in fibrinolysis through network pharmacology and metabolomics. While the results demonstrate that ginsenoside Rh7 influences specific pathways in vitro, the therapeutic efficacy in humans remains unknown.
The details
The research integrated network pharmacology with LC-MS/MS metabolomics to map how nine active ginsenoside components interact with metabolic pathways. Molecular docking analysis showed high binding affinity between ginsenoside Rh7 and core targets, including AKT1 and PIK3CA. In laboratory tests on venous endothelial cells, Rh7 intervention increased tissue-type plasminogen activator expression while reducing plasminogen activator inhibitor-1, suggesting a potential role in stabilizing fibrinolytic balance.
Timeline
Venous blood samples were collected 2 hours before surgery.
Follow-up venous blood samples were taken 24 hours after surgery.
Health Landscape
This study represents an effort to bridge traditional pharmacological interest in ginsenosides with modern molecular insights into vascular biology. It adds to the current trend of identifying natural compounds capable of modulating clotting pathways during major orthopedic interventions.
Because these findings are limited to laboratory experiments, they do not change current clinical practice or post-surgery recovery protocols. Patients preparing for hip surgery should continue to discuss their individual clotting risk and preventive measures directly with their surgeon.
The takeaway
Ginsenoside Rh7 shows promise in laboratory settings for regulating blood-clotting pathways after surgery. Future research will be needed to determine if these molecular findings hold potential for clinical applications in human patients.
Further reading
Learn more about the latest research and clinical approaches in our Stroke section.
More information
View the complete peer-reviewed research article for full data and methodology.
Source note: This article includes information reported by Nature.
Live Poll
Would you trust traditional herbal compounds to support your recovery after a major surgery?
